Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising incidence of animal diseases
3.2.1.2 Increasing animal healthcare expenditure
3.2.1.3 Rising adoption of pet insurance
3.2.2 Industry pitfalls & challenges
3.2.2.1 Shortage of trained veterinary professionals
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Isotonic crystalloids
5.3 Dextrose solutions
5.4 Synthetic colloids
5.5 Natural colloids
5.6 Parenteral nutrition
Chapter 6 Market Estimates and Forecast, By Indication, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Diabetic ketoacidosis
6.3 Pancreatitis
6.4 Anthrax
6.5 Chronic kidney disease
6.6 Nutritional support
6.7 Other indications
Chapter 7 Market Estimates and Forecast, By Animal Type, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Companion animals
7.3 Production animals
Chapter 8 Market Estimates and Forecast, By End-user, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Veterinary hospitals & clinics
8.3 Research institutes
8.4 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 B. Braun Melsungen AG
10.2 Ceva Santé Animale
10.3 Dechra Pharmaceuticals plc
10.4 Elanco Animal Health
10.5 Fresenius Kabi
10.6 Hospira (Pfizer Inc.)
10.7 Jorgensen Laboratories, LLC
10.8 Merck & Co. Inc.
10.9 Sykes Vet International Pty Ltd.
10.10 Zoetis, Inc.
